semaglutide nda FDA Warns on Certain Forms of Compounded FDA Approves Semaglutide (OZEMPIC) for

At twelve months, engaged Med+ members lost 29.1% more weight than those who used GLP-1s without corresponding behavioral support

10.1002/iub.2046 44 ZhangL.LiP.TangZ.DouQ.FengB

There are varieties of studies that confirm this conclusion

There is concern about effects on the liver and pancreas, and the possibility of cancers

What starting dose will my doctor pick

In line with laboratory-controlled studies demonstrating altered food preferences, the reduction in food intake among GLP-1 users is disproportionately associated with decreased consumption of processed foods, while intake of fruits and vegetables has increased overall